IDYA
Price
$22.16
Change
-$0.56 (-2.46%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
1.92B
73 days until earnings call
RCKT
Price
$10.30
Change
+$0.09 (+0.88%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
1.1B
47 days until earnings call
Ad is loading...

IDYA vs RCKT

Header iconIDYA vs RCKT Comparison
Open Charts IDYA vs RCKTBanner chart's image
IDEAYA Biosciences
Price$22.16
Change-$0.56 (-2.46%)
Volume$10.4K
Capitalization1.92B
Rocket Pharmaceuticals
Price$10.30
Change+$0.09 (+0.88%)
Volume$11.43K
Capitalization1.1B
IDYA vs RCKT Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. RCKT commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and RCKT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (IDYA: $22.72 vs. RCKT: $10.21)
Brand notoriety: IDYA and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 59% vs. RCKT: 129%
Market capitalization -- IDYA: $1.92B vs. RCKT: $1.1B
IDYA [@Biotechnology] is valued at $1.92B. RCKT’s [@Biotechnology] market capitalization is $1.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 0 green, 5 red.
According to our system of comparison, both IDYA and RCKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 3 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • IDYA’s TA Score: 3 bullish, 4 bearish.
  • RCKT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RCKT is a better buy in the short-term than IDYA.

Price Growth

IDYA (@Biotechnology) experienced а -8.57% price change this week, while RCKT (@Biotechnology) price change was -13.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

IDYA is expected to report earnings on May 13, 2025.

RCKT is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.92B) has a higher market cap than RCKT($1.1B). IDYA YTD gains are higher at: -11.595 vs. RCKT (-18.775). IDYA has higher annual earnings (EBITDA): -220.54M vs. RCKT (-247.25M). IDYA has more cash in the bank: 920M vs. RCKT (236M). IDYA has less debt than RCKT: IDYA (18.8M) vs RCKT (25.6M). IDYA has higher revenues than RCKT: IDYA (3.92M) vs RCKT (0).
IDYARCKTIDYA / RCKT
Capitalization1.92B1.1B175%
EBITDA-220.54M-247.25M89%
Gain YTD-11.595-18.77562%
P/E RatioN/AN/A-
Revenue3.92M0-
Total Cash920M236M390%
Total Debt18.8M25.6M73%
FUNDAMENTALS RATINGS
RCKT: Fundamental Ratings
RCKT
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYARCKT
RSI
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
73%
Aroon
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
82%
View a ticker or compare two or three
Ad is loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-2.32%
GRI - IDYA
54%
Loosely correlated
-3.83%
RCKT - IDYA
47%
Loosely correlated
-6.16%
PLRX - IDYA
47%
Loosely correlated
-8.16%
ETNB - IDYA
47%
Loosely correlated
-2.79%
INAB - IDYA
47%
Loosely correlated
-2.11%
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with FATE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
-6.16%
FATE - RCKT
52%
Loosely correlated
-5.30%
NTLA - RCKT
51%
Loosely correlated
-2.99%
DNLI - RCKT
51%
Loosely correlated
+0.79%
PLRX - RCKT
50%
Loosely correlated
-8.16%
PRME - RCKT
50%
Loosely correlated
+0.35%
More